Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Embolization Treatment for Uterine Fibroids

By HospiMedica staff writers
Posted on 30 Jul 2003
Symptomatic fibroid tumors can be treated with uterine fibroid embolization (UFE), a minimally invasive procedure that may reduce the number of uterine surgeries.

UFE can be used as an alternative to both hysterectomy and myomectomy. More...
An interventional radiologist injects small, specially engineered particles into the uterine arteries that supply blood to the fibroid. Once the particles stop the flow of blood to the fibroid, the tumor shrinks and symptoms are relieved. Usually, the fibroid shrinks to half its original size within the first three months following UFE. Because embolization is a permanent treatment, it is unusual for tumor regrowth to occur.

"Between 85-90% of UFE patients report reduced or completely alleviated symptoms and are happy with the procedure and its results,” noted Dr. Robert Vogelzang, professor and chief of vascular and interventional radiology at Northwestern University Medical School (Chicago, IL, USA; www.nums.nwu.edu). Dr. Vogelzang spoke about the procedure during a media briefing by the Radiological Society of North America (RSNA) in New York (NY, USA).

Patients with excessively large fibroids, fibroids outside the uterus, or active infections are not good UFE candidates. Long-term studies are needed to determine if UFE is uniformly safe for women who wish to become pregnant. A multicenter study indicated that successful pregnancies can occur after UFE.




Related Links:
Northwestern

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.